References
- Stenbeck M, Rosen M (eds). Cancer survival in Sweden in 1961–1991. Acta Oncol 1995; 34: (Suppl 4).
- Dickman PW, Hakulinen T, Luostarinen T, et al. Survival of cancer patients in Finland 1955–1994. Acta Oncol 1999; 38: (Suppl 12).
- Cancer in Norway 2000. Oslo, Norway: Institute for Popula-tion-based Cancer Research, 2002.
- Carstensen B, Storm H, Schou G (eds). Survival of Danish cancer patients, 1943–1987. APMIS 1993; 101: (Suppl 33).
- The Eurocare II study. Survival of adult cancer patients in Europe diagnosed from 1978-1989. Eur J Cancer 1998; 34: 2137–278.
- Berrino F, Capocaccia R, Esteve J, et al. (eds). Survival of cancer patients in Europe: the Eurocare II study. IARC Scientific Publication No. 151. Lyon: International Agency for Research on Cancer, 1999.
- Brenner H, Söderman B, Hakulinen T. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370 000 cancer patients in Finland. Int J Epidemiol 2002; 31: 456–62.
- Mattson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases on death certificates in 1978. Acta Radiol Oncol 1984; 23: 305–13.
- Hakulinen T. On long-term relative survival rates. J Chronic Dis 1977; 30: 431–43.
- Therneau T, Sick J, Bergstralh E, Offord J. Expected survival based on hazard rates. Technical Report No. 52. Mayo Foundation, 1994.
- Baade P. Relative survival analysis in SAS. An update on the Mayo Clinic Macros. Brisbane: Health Information Centre, Queensland Health, 2000.
- Voutilainen ET, Dickman PW, Hakulinen T. SURV2: Relative survival analysis program version 2.0213. Helsinki: Finnish Cancer Registry, 1998.
- Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38: 933–42.
- Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note no. 10. Bethesda, MD: End Results Evaluation Section, National Cancer Institute; 1959.
- Hakama M, Hakulinen T. Estimating the expectation of life in cancer survival studies with incomplete follow-up information. J Chronic Dis 1977; 30: 585–97.
- Stockeld D, Tennvall J, Wagenius G, et al. A Swedish study of chemoradiation in squamous cell carcinoma of the esophagus. Acta Oncol 2001; 40: 566–73.
- Albertsson M. Chemoradiotherapy of esophageal cancer. Acta Oncol 2002; 41: 118–23.
- Lagergren J. Cancer of the esophagus and gastric cardia. Etiological aspects. Thesis. Karolinska Institutet, Stockholm, 1999.
- Cancer Incidence in Sweden 2000. Centre for Epidemiology. National Board of Health and Welfare. Official statistics of Sweden. Health and diseases 2002: 5. Available at http:// www.sos.se/fulltext/42/2002-42-5/summary.htm (2002).
- Janunger KG, Hafstrom L, Nygren P, Glimelius B, for the SBU-group. Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in gastric cancer. Acta Oncol 2001; 40: 309–26.
- Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiother-apy after surgery compared with surgery alone for adenocarci-noma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725–30.
- Wiedenmann B, Plöckinger U. Neuroendocrine gastroentero-pancreatic tumours. In: Souhami RL, Tannock I, Hohenberger P, Horiot J-C, eds. Oxford textbook of oncology, 2nd ed. Oxford University Press; 2001. p. 2819–33.
- Surgery for colorectal cancer in elderly patients: a systematic review. Colorectal Cancer Collaborative Group. Lancet 2000; 356: 968–74.
- Ragnhammar P, Hafstrom L, Nygren P, Glimelius B, for the SBU-group. Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 2001; 40: 282–308.
- Dahlberg M, Glimelius B, Pahlman L. Changing strategy for rectal cancer is associated with improved outcome. Br J Surg 1999; 86: 379–84.
- Glimelius B, Isacsson U. Preoperative radiotherapy for rectal cancer-is 5 x 5 Gy a good or a bad schedule? Acta Oncol 2001; 40: 958–67.
- Hussain SA, Ferry DR, El-Gazzaz G, et al. Hepatocellular carcinoma. Ann Oncol 2001; 12: 161–72.
- Permert J, Hafstrom L, Nygren P, Glimelius B, for the SBU-group. Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in pancreatic cancer. Acta Oncol 2001; 40: 361–70.
- Neoptolemos JP, Dunn JA, Stocken DD, et al. Adjuvant chemotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001; 358: 1576–85.
- Frödin J-E. Lung cancer. In: Radiotherapy for cancer. Acta Oncol 1996; 35(Suppl 7): 46–53.
- Qsterlind K. Chemotherapy in small cell lung cancer. Eur Respir J 2001; 18: 1026–43.
- Sörenson S, Glimelius B, Nygren P, for the SBU-group. Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in non-small cell lung cancer. Acta Oncol 2001; 40: 327–39.
- Hansen HH. An update on management of lung cancer. Acta Oncol 2002; 41: 500–6.
- Rosen M, Stenbeck M. Entydiga resultat i förvantad riktning. Läkaridningen 2000; 97; 859–60. (In Swedish.)
- Jonsson H, 'Romberg S, Nystrom L, et al. Service screening with mammography in Sweden. Evaluation of effects from screening in age 40-49 years on the breast cancer mortality. Acta Oncol 2000; 39: 617–23.
- Jonsson H, Nystrom L, Tömberg S, Lenner P. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. J Med Screen 2001; 8: 152–60.
- Bergh J, Jonsson PE, Glimelius B, Nygren P, for the SBU-group. Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in breast cancer. Acta Oncol 2001; 40: 253–81.
- Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002; 359: 909–19.
- Duffy SW, Tabar L, Chen HH, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 2002; 95: 458–69.
- Dillner J. Cervical cancer screening in Sweden. Eur J Cancer 2000; 36: 2255–9.
- Einhorn N. Cervical cancer. In: Radiotherapy for cancer. Acta Oncol 1996; 35(Suppl 7): 75–80.
- Hogberg T, Glimelius B, Nygren P, for the SBU-group. Swedish Council of Technology Assessment in Health Care. A systema-tic overview of chemotherapy effects in ovarian cancer. Acta Oncol 2001; 40: 340–60.
- Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002; 347: 781–9.
- Horwich A, Waxman J, Abel P, Laniado M, Deamaley DP. Tumours of the prostate. In: Souhami RL, Tannock I, Hohenberger P, Horiot J-C, eds. Oxford textbook of oncology, 2nd ed. Oxford University Press; 2001. p. 1939–72.
- Horwich A, Mason M, Hendry W. Testicular tumours. In: Souhami RL, Tannock I, Hohenberger P, Horiot J-C, eds. Oxford textbook of oncology, 2nd ed. Oxford University Press; 2001. p. 2007–35.
- Nilsson S, Ragnhammar P, Glimelius B, Nygren P. A systematic overview of chemotherapy effects in urothelial bladder cancer. Acta Oncol 2001; 40: 371–90.
- Elwood M, Jospon J. Melanoma and sun exposure: an overview of published studies. Int J Cancer 1997; 73: 198–203.
- Eggermont AMM, Autier P, Keilholz U. Cutaneous malignant melanoma. In: Souhami RL, Tannock I, Hohenberger P, Horiot J-C, eds. Oxford textbook of oncology, 2nd ed. Oxford University Press; 2001. p. 1175–211.
- Brada M, Collins VP, Doward NL, Thomas DG. Tumours of the brain and spinal cord in adults. In: Souhami RL, Tannock I, Hohenberger P, Horiot J-C, eds. Oxford textbook of oncology, 2nd ed. Oxford University Press; 2001. p. 2707–53.
- Blomgren H. Brain tumors. Acta Oncol 1996; 35(Suppl 7): 16–21.
- Nutting C, Brada M, Brazil L, et al. Radiotherapy in the treatment of benign meningioma of the skull base. Neurosur-gery 1991; 90: 823–7.
- Frilling A. Carcinoma of the thyroid. In: Souhami RL, Tannock I, Hohenberger P, Horiot J-C, eds. Oxford textbook of oncology, 2nd ed. Oxford University Press; 2001. p. 2757–69.
- Whelan J, Cannon S. Osteosarcoma. In: Souhami RL, Tannock I, Hohenberger P, Horiot J-C, eds. Oxford textbook of oncology, 2nd ed. Oxford University Press; 2001. p. 2553–70.
- O'Sullivan B, Bell RS, Bramwell VHC. Sarcomas of the soft tissues. In: Souhami RL, Tannock I, Hohenberger P, Horiot J- C, eds. Oxford textbook of oncology, 2nd ed. Oxford University Press; 2001. p. 2495–523.
- Kimby E, Brandt L, Nygren P, Glimelius B, for the SBU-group. Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in aggressive non-Hodgkin's lymphoma. Acta Oncol 2001; 40: 198–212.
- Brandt L, Kimby E, Nygren P, Glimelius B, for the SBU-group. Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in indolent non-Hodgkin's lymphoma. Acta Oncol 2001; 40: 213–23.
- Brandt L, Kimby E, Nygren P, Glimelius B, for the SBU-group. Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in Hodgkin's disease. Acta Oncol 2001; 40: 185–97.
- Morgan G, Selby P. Myeloma. In: Souhami RL, Tannock I, Hohenberger P, Horiot J-C, eds. Oxford textbook of oncology, 2nd ed. Oxford University Press; 2001. p. 2419–55.
- Mellstedt H. Progress in the understanding of the biology and the treatment of multiple myeloma-a cure might be around the corner. Acta Oncol 2000; 39: 763–4.
- Pui CH. Acute lymphoblastic leukaemia in children. Curr Opin Oncol 2000; 12: 3–12.
- Kimby E, Nygren P, Glimelius B, for the SBU-group. Swedish Council of Technology Assessment in Health Care. A systema-tic overview of chemotherapy effects in acute myeloid leukae-mia. Acta Oncol 2001; 40: 231–52.
- Mughal TI, Goldman JM. Chronic myeloid leukaemia. In: Souhami RL, Tannock I, Hohenberger P, Horiot J-C, eds. Oxford textbook of oncology, 2nd ed. Oxford University Press; 2001. p. 2235–54.
- Frodin JE, Jonsson E, Moller T, Werko L. Radiotherapy in Sweden-a study of present use in relation to the literature and an estimate of future trends. Acta Oncol 1996; 35: 967–79.
- Glimelius B, Bergh J, Brandt L, et al. The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types-summary and conclusions. Acta Oncol 2001; 40: 135–40.
- Nygren P, Glimelius B. The Swedish Council on Technology Assessment in Health Care (SBU) report on cancer chemotherapy-project objectives, the working process, key definitions and general aspects on cancer trial methodology and interpretation. Acta Oncol 2001; 40: 155–65.
- Nygren P. What is cancer chemotherapy? Acta Oncol 2001; 40: 166–74.
- Brenner H, Hakulinen T. Advanced detection of time trends in long-term cancer patient survival: experience from 50 years of cancer registration in Finland. Am J Epidemiol 2002; 156: 576.